Triple
T187826
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Children's Hospital of Philadelphia |
E4020
|
entity |
| Predicate | hasResearchCenter |
P40
|
FINISHED |
| Object |
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
|
E23880
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Cellular and Molecular Therapeutics | Statement: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Cellular and Molecular Therapeutics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Center for Cellular and Molecular Therapeutics Context triple: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Cellular and Molecular Therapeutics]
-
A.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
-
B.
Wistar Institute
The Wistar Institute is a renowned biomedical research center in Philadelphia known for its pioneering work in cancer, immunology, and vaccine development.
-
C.
Koch Institute for Integrative Cancer Research
The Koch Institute for Integrative Cancer Research is an MIT-based interdisciplinary research center that combines biology, engineering, and technology to advance the understanding, detection, and treatment of cancer.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
NIH Clinical Center
The NIH Clinical Center is the research hospital of the U.S. National Institutes of Health, dedicated to conducting and supporting clinical studies that translate scientific discoveries into medical advances.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Center for Cellular and Molecular Therapeutics Triple: [Children's Hospital of Philadelphia, hasResearchCenter, Center for Cellular and Molecular Therapeutics]
Generated description
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Center for Cellular and Molecular Therapeutics Target entity description: The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
A.
Center for Cancer Research
The Center for Cancer Research is the intramural research arm of the U.S. National Cancer Institute, conducting basic, translational, and clinical studies to advance cancer prevention, diagnosis, and treatment.
-
B.
Wistar Institute
The Wistar Institute is a renowned biomedical research center in Philadelphia known for its pioneering work in cancer, immunology, and vaccine development.
-
C.
Koch Institute for Integrative Cancer Research
The Koch Institute for Integrative Cancer Research is an MIT-based interdisciplinary research center that combines biology, engineering, and technology to advance the understanding, detection, and treatment of cancer.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
NIH Clinical Center
The NIH Clinical Center is the research hospital of the U.S. National Institutes of Health, dedicated to conducting and supporting clinical studies that translate scientific discoveries into medical advances.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a25497e2f08190a040f8c6e1842643 |
completed | Feb. 28, 2026, 2:36 a.m. |
| NER | Named-entity recognition | batch_69a2594940e48190a3d8efbce46241c3 |
completed | Feb. 28, 2026, 2:56 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a30287094c8190ad4669e856a29f6c |
completed | Feb. 28, 2026, 2:58 p.m. |
| NEDg | Description generation | batch_69a3047bf9588190a147cea4f7b74f46 |
completed | Feb. 28, 2026, 3:06 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a304fdf7888190b0e14ca4eeffe397 |
completed | Feb. 28, 2026, 3:08 p.m. |
Created at: Feb. 28, 2026, 2:40 a.m.